Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.240 | 16 | 20348925 | missense variant | A/G | snv |
|
0.010 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
1.000 | 16 | 20337383 | missense variant | C/A;T | snv | 4.0E-06; 1.3E-04 |
|
0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
1.000 | 16 | 20349795 | missense variant | C/T | snv | 5.4E-05 |
|
0.010 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
0.827 | 0.200 | 16 | 20356368 | upstream gene variant | G/T | snv | 0.14 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2012 | 2014 | |||||||
|
0.827 | 0.200 | 16 | 20354332 | intron variant | A/G | snv | 0.23 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 16 | 20343125 | intron variant | G/A | snv | 1.1E-02 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.200 | 16 | 20356368 | upstream gene variant | G/T | snv | 0.14 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.730 | 0.800 | 5 | 2010 | 2018 | |||||||
|
1.000 | 0.040 | 16 | 20356323 | upstream gene variant | C/A;T | snv |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.827 | 0.200 | 16 | 20353266 | intron variant | A/G | snv | 0.20 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.827 | 0.200 | 16 | 20356368 | upstream gene variant | G/T | snv | 0.14 |
|
0.700 | 1.000 | 2 | 2010 | 2016 | ||||||||
|
1.000 | 0.080 | 16 | 20355185 | intron variant | T/C | snv | 0.24 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 16 | 20337383 | missense variant | C/A;T | snv | 4.0E-06; 1.3E-04 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
0.827 | 0.200 | 16 | 20354332 | intron variant | A/G | snv | 0.23 |
|
Endocrine System Diseases | 0.710 | 1.000 | 2 | 2011 | 2018 | |||||||
|
0.827 | 0.200 | 16 | 20356368 | upstream gene variant | G/T | snv | 0.14 |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 16 | 20356323 | upstream gene variant | C/A;T | snv |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.827 | 0.200 | 16 | 20354332 | intron variant | A/G | snv | 0.23 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.710 | 1.000 | 2 | 2011 | 2018 | |||||||
|
0.827 | 0.200 | 16 | 20356368 | upstream gene variant | G/T | snv | 0.14 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 16 | 20356323 | upstream gene variant | C/A;T | snv |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.827 | 0.200 | 16 | 20356368 | upstream gene variant | G/T | snv | 0.14 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.200 | 16 | 20354332 | intron variant | A/G | snv | 0.23 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.827 | 0.200 | 16 | 20353266 | intron variant | A/G | snv | 0.20 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.200 | 16 | 20353266 | intron variant | A/G | snv | 0.20 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.200 | 16 | 20354332 | intron variant | A/G | snv | 0.23 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.827 | 0.200 | 16 | 20354332 | intron variant | A/G | snv | 0.23 |
|
Cardiovascular Diseases | 0.700 | 0 | ||||||||||
|
0.827 | 0.200 | 16 | 20356368 | upstream gene variant | G/T | snv | 0.14 |
|
0.800 | 1.000 | 2 | 2013 | 2016 |